Efficacy of Unani compound formulations and regimen in the management of Obesity
Not Applicable
- Conditions
- Health Condition 1: E668- Other obesity
- Registration Number
- CTRI/2023/08/056675
- Lead Sponsor
- Department of Ilaj Bit Tadbeer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
BMI more than 30 and less than 39.9
Waist circumference more than 102 cm in men and more than 88 cm in women
patient willing to Participate in the study and ready to follow the instructions
Exclusion Criteria
Age below 20 years and above 60 years
BMI less than 30 and more than 39.9
Waist circumference less than 102 cm in men and less than 88 cm in women
Pregnant and lactating Women
Patients who fail to give written consent
Patient having uncontrolled cardiac, liver and renal disorder
unstable and bed ridden patients
Patient of portal hypertension and bleeding disorder
patient with uncontrolled primary hypertension and diabetes mellitus
patients with endocrine disorders that is hypothyroidism, cushing syndrome
patients who do not cooperate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body weight decreases <br/ ><br>BMI decreases <br/ ><br>Waist circumference decreases <br/ ><br>waist hip ratio <br/ ><br>upper arm circumference <br/ ><br>skin fold thickness <br/ ><br>lipid profile total cholesterol & triglyceridesTimepoint: Assessment of all parameters at inititation of the study at 0 day 15 day 30 day 45 day & 60 day. <br/ ><br>Assessment of lipid profile at 0 day & at the end of study 60 day
- Secondary Outcome Measures
Name Time Method Restricted movement <br/ ><br>Joints pain <br/ ><br>Weakness & lethargyTimepoint: assessment of all symptoms at initiation of the study at 0 day 15 day 30 day 45 day & 60 day